Detection of antibodies to Brucella canis, the causative agent of canine brucellosis, by indirect fluorescent antibody test; samples tested at 1:50, 1:100, and 1:200 dilutions.
This test is for export purposes only. Detection of Brucella canis antibodies by microagglutination and agar gel immunodiffusion (AGID). The Slide Agglutination Test/AGID is only available as the initial screening test for export samples.
Quantification of antibodies against two Brucella canis antigens in serum.
All non-export samples will be screened with this assay; samples with non-negative results will undergo confirmatory testing with Canine Brucella Slide Agglutination/AGID II tests (CANBR) at no additional cost.
Detection of infectious agents (i.e. Hepatozoon spp., bacteria, spirochetes) and neoplastic cells (i.e. mast cells) by microscopic evaluation of the buffy coat.
Measurement of c-reactive protein (CRP) in dogs. This test is useful to confirm the presence of underlying inflammation (particularly in the absence of other clinical or laboratory indicators of inflammation) and to monitor response to therapy.